HEALTH NEWS
Medicaid GLP-1 coverage cuts: 7 states and counting
Short answer: as of October 1, 2026, Rhode Island Medicaid stopped covering GLP-1 medications prescribed only for weight loss —Wegovy, Zepbound, Saxenda and the new Foundayo pill—. Seven states have now cut this coverage in 2026, and California did it earlier this year. If your prescription is for type 2 diabetes, you stay covered. Without insurance, these drugs run over $1,000 a month.
Educational content prepared with official health sources. Professional medical review pending.
No personalized diagnoses: consult your doctor.
📅 Published October 6, 2026 · Health news · 5-minute read
If you pick up your medication at the pharmacy every month and all you pay is the copay, this matters to you.
On October 1, thousands of people in Rhode Island walked into the pharmacy and got the news: their Medicaid no longer covered their weight-loss prescription. No time to prepare. No exception for people already in treatment.
What changed
Rhode Island Medicaid took four medications off its list when prescribed only for weight loss: Wegovy, Zepbound, Saxenda and Foundayo, the new pill. Coverage ended October 1, 2026.
The state says it paid for nearly 25,000 of these prescriptions last year and expects to save about $6.3 million —over $20 million counting federal funds.
To give you an idea of the uninsured cost: list prices run $12,000 to $16,000 a year. More than $1,000 every month, out of pocket.
Not the only state
Rhode Island is the seventh state to do this in 2026. California —home to most of our readers, on Medi-Cal— cut earlier this year. So did New Hampshire, Pennsylvania and South Carolina. Massachusetts ended obesity-only coverage on July 3, and a Utah pilot program expired June 30.
Every state sets its own rules. What happened in Rhode Island does not mean your plan changes tomorrow, but the trend is clear.
The exception that matters
Here is the most important part: if your prescription is for type 2 diabetes, coverage continues. The cut applies only to drugs prescribed solely for weight loss.
And there is another door: if your doctor believes you need the medication for another medical reason, a new prior authorization can be requested. It is not automatic, but the path exists.
The American Diabetes Association has already voiced concern about restricting obesity treatment. This story is not over.
3 questions for your doctor
If you take any of these medications, do not wait for the letter. At your next visit —or sooner, by phone— ask this:
1. Is my prescription still covered with my current diagnosis?
2. If I lose coverage, do I qualify for prior authorization for another medical reason?
3. What options do I have if I lose coverage?
And one more, not a question but a rule: do not stop the medication on your own. Stopping suddenly brings its own problems; any change goes through your doctor.
What to do if you lose coverage
First, talk to your doctor before your medication runs out. Second, read your plan's letter: by law they must notify you of changes. Third, if you move states, check the new state's rules —they vary a lot from one to another.
Lost your coverage?
A specialist can review your case: your diagnosis, your options, and whether you qualify for prior authorization. Do not sit with the doubt, and do not stop your treatment alone.
Talk to a specialist →Educational content. Not medical advice and not a substitute for consulting a healthcare professional.
Frequently asked questions
Which drugs did Rhode Island Medicaid stop covering?
Wegovy, Zepbound, Saxenda and the Foundayo pill, when prescribed only for weight loss. Coverage ended October 1, 2026, with no exception for patients already in treatment.
Am I still covered if my prescription is for type 2 diabetes?
Yes. Prescriptions for type 2 diabetes remain covered; the cut applies only to drugs prescribed solely for weight loss.
What if I was already taking one of these medications?
In Rhode Island there was no protection for current patients: coverage ended October 1. Talk to your doctor before your medication runs out and ask about prior authorization.
How much do these drugs cost without insurance?
List prices run $12,000 to $16,000 a year —more than $1,000 a month out of pocket.
Will my state cut coverage too?
Seven states have cut in 2026: California, New Hampshire, Pennsylvania and South Carolina cut early in the year; Massachusetts ended obesity-only coverage July 3; Utah's pilot expired June 30; Rhode Island joined October 1. Rules vary by state: read your plan's letter.
References
- Medical Daily, "Rhode Island Medicaid GLP-1 weight-loss coverage ends" (October 2026; coverage ended Oct 1; no protection for current patients; 24,971 prescriptions in FY2025; projected savings): medicaldaily.com.
- MedPath Trial, "Rhode Island Medicaid drops coverage for Wegovy, Zepbound and other GLP-1 drugs" (October 2026; affected drugs; type 2 diabetes stays covered; prior authorization for other uses): trial.medpath.com.
- Providence Business News, "These 5 changes for Rhode Island Medicaid take effect Oct. 1" (October 2026; changes effective Oct 1): pbn.com.
- healthinsurance.org, "Does health insurance cover GLP-1 medications for weight loss?" (guide; coverage varies by state and plan): healthinsurance.org.
📷 Illustrative photo generated for this article.
